...
首页> 外文期刊>Hepatology research: the official journal of the Japan Society of Hepatology >Oral application of 1,7-dimethylxanthine (paraxanthine) attenuates the formation of experimental cholestatic liver fibrosis.
【24h】

Oral application of 1,7-dimethylxanthine (paraxanthine) attenuates the formation of experimental cholestatic liver fibrosis.

机译:口服1,7-二甲基黄嘌呤(对黄嘌呤)可减轻实验性胆汁淤积性肝纤维化的形成。

获取原文
获取原文并翻译 | 示例
           

摘要

Aim: Several epidemiological studies suggest a beneficial effect of coffee consumption on the formation and progression of fibrogenic diseases, particularly of the liver. Recent data now point to a modulation of transforming growth factor-beta (TGF-beta) signaling by paraxanthine (1,7-dimethylxanthine [1,7-DMX]), the demethylated primary metabolite of caffeine Methods: Twenty adult Sprague-Dawley rats were bile duct ligated (BDL) or sham operated with or without concomitant oral 1,7-DMX (1 mM) application. Serum was investigated by standard biochemical analysis, in-house connective tissue growth factor (CTGF), enzyme linked immunosorbent assay (ELISA) or liquid chromatography-mass spectrometry analysis. Liver tissue was stained using hematoxylin-eosin (HE) and Sirius-red staining. Whole liver lysates, primary rat hepatocytes (PC) and hepatic stellate cells (HSC) were investigated by CTGF, and total Smad2/3 Western blot analysis, CTGF reporter gene assay or an in-house malondialdehyde ELISA. Results: The in vitro 50% inhibitory dose (ID50) of 1,7-DMX was 0.95 mM by for CTGF promoter activity and protein expression in PC and 1.25 mM for protein expression in HSC. Oral 1,7-DMX application (1 mM) attenuated cholestatic hepatocellular injury in vivo as determined by biochemical serum analysis and reduced intercellular collagen deposition in the cholestatic rat liver (HE- and Sirius-red staining). Western Blot analysis of whole liver lysates revealed a reduction of intrahepatic concentrations of Smad2/3 and CTGF following oral 1,7-DMX intake. However, serum CTGF concentrations were not reduced in 1,7-DMX treated BDL rats. Oral 1,7-DMX furthermore led to a reduction of intrahepatic lipid peroxidation (malondialdehyde concentrations) as markers of oxidative stress in BDL rats. Conclusion: Our pilot study warrants further studies of 1,7-DMX as a potential new drug to fight fibrotic processes, not just of the liver.
机译:目的:几项流行病学研究表明,喝咖啡对纤维化疾病(尤其是肝脏)的形成和发展具有有益作用。现在的最新数据表明,咖啡因的去甲基化主要代谢产物对黄嘌呤(1,7-二甲基黄嘌呤[1,7-DMX])可以调节转化生长因子-β(TGF-β)信号传导。方法:成年Sprague-Dawley大鼠20只胆管结扎术(BDL)或假手术,有或没有口服1,7-DMX(1 mM)。通过标准生化分析,内部结缔组织生长因子(CTGF),酶联免疫吸附测定(ELISA)或液相色谱-质谱分析法研究血清。肝组织使用苏木精-伊红(HE)和Sirius-red染色。通过CTGF,全Smad2 / 3 Western印迹分析,CTGF报告基因分析或内部丙二醛ELISA对全肝裂解液,大鼠原代肝细胞(PC)和肝星状细胞(HSC)进行了研究。结果:1,7-DMX的体外50%抑制剂量(ID50)对于CTGF启动子活性和PC中的蛋白表达为0.95 mM,对于HSC中的蛋白表达为1.25 mM。通过生化血清分析确定,口服1,7-DMX(1 mM)可减轻体内的胆汁淤积性肝细胞损伤,并减少胆汁淤积大鼠肝脏中的细胞间胶原沉积(HE-和Sirius-红色染色)。对全肝裂解物的蛋白质印迹分析表明,口服1,7-DMX摄入后,肝内Smad2 / 3和CTGF浓度降低。但是,在1,7-DMX处理的BDL大鼠中,血清CTGF浓度并未降低。口服1,7-DMX进一步降低了肝内脂质过氧化(丙二醛浓度),作为BDL大鼠氧化应激的标志物。结论:我们的初步研究值得进一步研究1,7-DMX作为对抗纤维化过程的潜在新药,而不仅仅是肝脏。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号